Clicky

Athira Pharma, Inc.(ATHA) News

Date Title
May 14 Athira Pharma to present data from first-in-human Phase 1 trial of ATH-1105
May 13 Athira Pharma to Present Data from First-in-Human Phase 1 Clinical Trial of ATH-1105 at the 4th Annual ALS Drug Development Summit
May 9 Athira Pharma Reports First Quarter 2025 Financial Results and Pipeline and Business Updates
Aug 7 Is Athira Pharma (ATHA) Stock Outpacing Its Medical Peers This Year?
Jun 30 retail investors who own 35% along with institutions invested in Athira Pharma, Inc. (NASDAQ:ATHA) saw increase in their holdings value last week
Jun 3 We're A Little Worried About Athira Pharma's (NASDAQ:ATHA) Cash Burn Rate
May 15 Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates
May 7 Sidoti Events, LLC's Virtual May Micro-Cap Conference
May 2 Athira Pharma to Participate in Upcoming May Conferences
Apr 23 One Athira Pharma Insider Raised Their Stake In The Previous Year
Apr 15 Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
Apr 11 Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s Disease
Apr 3 Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting
Mar 29 Is Stryker (SYK) Stock Outpacing Its Medical Peers This Year?
Mar 8 Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2024 International Conference
Mar 1 Is Arcutis Biotherapeutics (ARQT) Outperforming Other Medical Stocks This Year?
Feb 28 Athira Pharma, Inc. (ATHA) is a Great Momentum Stock: Should You Buy?
Dec 5 Sidoti Events, LLC's Virtual December Small-Cap Conference
Nov 29 Athira Pharma to Participate in Sidoti December Small Cap Investor Conference
Nov 28 Athira Pharma Announces Upcoming Presentation at Motor Neurone Disease Association’s 34ᵗʰ International Symposium on ALS/MND